SuperworthCorbus Pharmaceuticals shares outstanding CRBP
Diluted shares outstanding, averaged over each quarter, from 2013.
- Latest quarter, to Jun 30, 2026
- 19.4M
- On a year earlier
- +58.6%
- more shares
Corbus Pharmaceuticals had 19.4M diluted shares outstanding on average in Q2 FY26, the quarter to Jun 30, 2026.
That is 58.6% more than a year earlier, so each share owns a little less of the company.
Shares outstanding over time
Fiscal year by fiscal year
| Fiscal year | Shares, fourth quarter | Change |
|---|---|---|
| FY2025 | 16.5M | +35% |
| FY2024 | 12.2M | +175% |
| FY2023 | 4.4M | +6% |
| FY2022 | 4.2M | −0% |
| FY2021 | 4.2M | +43% |
| FY2020 | 2.9M | +35% |
| FY2019 | 2.2M | +13% |
| FY2018 | 1.9M | +6% |
| FY2017 | 1.8M | +21% |
| FY2016 | 1.5M | +18% |
| FY2015 | 1.3M | +45% |
| FY2014 | 861.6K | +271% |
| FY2013 | 232.2K | n/a |
Each fiscal year is the twelve months to its fourth quarter, shown as the fourth quarter's average share count.
Quarter by quarter
| Quarter | Ended | Shares outstanding | On a year earlier |
|---|---|---|---|
| Q2 FY26 | 19.4M | +59% | |
| Q1 FY26 | 18.7M | +53% | |
| Q4 FY25 | 16.5M | +35% | |
| Q3 FY25 | 12.3M | +2% | |
| Q2 FY25 | 12.2M | +11% | |
| Q1 FY25 | 12.2M | +47% | |
| Q4 FY24 | 12.2M | +175% | |
| Q3 FY24 | 12M | +172% | |
| Q2 FY24 | 11.1M | +158% | |
| Q1 FY24 | 8.3M | +99% | |
| Q4 FY23 | 4.4M | +6% | |
| Q3 FY23 | 4.4M | +6% |
What the shares outstanding tells you
Diluted shares outstanding, averaged over the period. Fewer shares means each one owns more of the company.
A falling count usually means buybacks. A rising one means stock pay, acquisitions paid in shares or new shares sold.
More on Corbus Pharmaceuticals
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.